Cristina Longo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Cristina Longo has a total of 125 co-authors. Here are the top co-authors by number of shared publications:
Lucie Blais
Faculty of Pharmacy, University of Montreal, Montreal, Québec, Canada; Research Centre, CIUSSS du Nord-de-l'Île-de-Montréal, Hôpital du Sacré-Cœur de Montréal, Montréal, Québec, Canada
5 shared publicationsAmélie Forget
Faculty of Pharmacy, University of Montreal, Montreal, Québec, Canada; Research Centre, CIUSSS du Nord-de-l'Île-de-Montréal, Hôpital du Sacré-Cœur de Montréal, Montréal, Québec, Canada
4 shared publications- Anke-Hilse Maitland-Van der Zee
Department of Pulmonary Medicine, Amsterdam UMC University of Amsterdam Amsterdam The Netherlands
4 shared publications Francine M. Ducharme
Research Centre, Centre Hospitalier Universitaire Sainte-Justine, Montreal, Québec, Canada; Department of Pediatrics, University of Montreal, Montreal, Québec, Canada; Department of Social and Preventive Medicine, Montreal, Québec, Canada
4 shared publicationsGillian Bartlett
McGill University Faculty of Medicine
4 shared publications- Anne Hicks
Department of Pediatrics University of Alberta Edmonton Alberta Canada
3 shared publications
Latest Publications
- Open Access
- 7 September 2026
- Published by Wiley in Birth Defects Research
- Vol. 118 (9)
Evaluating the Performance of Traditional Pharmacoepidemiologic and Machine Learning Models to Predict Pregnancies at Risk of Major Congenital Malformations
Background: With approximately 50% of pregnancies being unplanned, there is an unintended exposure to potential feto‐toxic drugs that may cause major congenital malformations (MCM). This study aims to compare the predictive performance between traditional pharmacoepidemiologic (PE) and machine learning (ML) models. Methods: We conducted a cohort study within the Quebec Pregnancy Cohort, including all pregnancies covered by Quebec's prescription drug insurance program and their children from 01/1998 to 12/2015. Medication exposures, comorbidities, and women's characteristics 12 months before pregnancy and during the first trimester were considered. Robust Poisson models were used to obtain adjusted risk ratios (aRR) and 95% confidence intervals (CI) of predictors. Logistic regression, robust Poisson, K‐Nearest Neighbors, Random Forest, XGBoost, Naïve bayes, Multilayer Perceptron, and Support Vector Machine were developed to predict pregnancies at risk of MCM. Sensitivity, specificity, PPV, NPV, accuracy, ROC‐AUCs, PR‐AUCs, and F1‐score were used to evaluate the performance of predictive models. Results: We analyzed 213,744 pregnancies, finding a 9.7% prevalence of MCM. Logistic regression had the highest discriminative power across models at predicting MCM, with a ROC‐AUC of 53.3% and the highest sensitivity (41.5%) and F1‐score (46.6%). KNN had the highest specificity (97.9%) but the lowest sensitivity (2.3%). Robust Poisson performed similarly to logistic regression, with the highest accuracy (52.3%). Robust Poisson performed slightly better than logistic regression at classifying organ‐specific malformations. All models showed poor overall predictive performance. Results were robust across sensitivity analyses. Conclusion: There is insufficient evidence for the superiority of ML over traditional pharmacoepidemiologic modeling in predicting MCM.
- 7 September 2026
- Published by Wiley in Birth Defects Research
- Vol. 118 (9)
Open AccessEvaluating the Performance of Traditional Pharmacoepidemiologic and Machine Learning Models to Predict Pregnancies at Risk of Major Congenital Malformations
Background: With approximately 50% of pregnancies being unplanned, there is an unintended exposure to potential feto‐toxic drugs that may cause major congenital malformations (MCM). This study aims to compare the predictive performance between traditional pharmacoepidemiologic (PE) and machine learning (ML) models. Methods: We conducted a cohort study within the Quebec Pregnancy Cohort, including all pregnancies covered by Quebec's prescription drug insurance program and their children from 01/1998 to 12/2015. Medication exposures, comorbidities, and women's characteristics 12 months before pregnancy and during the first trimester were considered. Robust Poisson models were used to obtain adjusted risk ratios (aRR) and 95% confidence intervals (CI) of predictors. Logistic regression, robust Poisson, K‐Nearest Neighbors, Random Forest, XGBoost, Naïve bayes, Multilayer Perceptron, and Support Vector Machine were developed to predict pregnancies at risk of MCM. Sensitivity, specificity, PPV, NPV, accuracy, ROC‐AUCs, PR‐AUCs, and F1‐score were used to evaluate the performance of predictive models. Results: We analyzed 213,744 pregnancies, finding a 9.7% prevalence of MCM. Logistic regression had the highest discriminative power across models at predicting MCM, with a ROC‐AUC of 53.3% and the highest sensitivity (41.5%) and F1‐score (46.6%). KNN had the highest specificity (97.9%) but the lowest sensitivity (2.3%). Robust Poisson performed similarly to logistic regression, with the highest accuracy (52.3%). Robust Poisson performed slightly better than logistic regression at classifying organ‐specific malformations. All models showed poor overall predictive performance. Results were robust across sensitivity analyses. Conclusion: There is insufficient evidence for the superiority of ML over traditional pharmacoepidemiologic modeling in predicting MCM.
- 27 August 2026
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 68 (4) , 2601143
A primer on target trial emulation for respiratory research
- 27 August 2026
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 68 (4) , 2601143
A primer on target trial emulation for respiratory research
- Open Access
- 25 August 2026
- Published by Elsevier in Journal of Allergy and Clinical Immunology: Global
- Vol. 5 (6)
Remission in moderate-to-severe pediatric asthma: Definitions, assessment, prevalence, predictors, and outcomes—a scoping review
- 25 August 2026
- Published by Elsevier in Journal of Allergy and Clinical Immunology: Global
- Vol. 5 (6)
Open AccessRemission in moderate-to-severe pediatric asthma: Definitions, assessment, prevalence, predictors, and outcomes—a scoping review
- Open Access
- 10 June 2026
- Published by Taylor & Francis in Canadian Journal of Respiratory, Critical Care, and Sleep Medicine
- Vol. 10 (4) , 1-9
2025 Canadian Pediatric Severe Asthma Stakeholders’ Forum proceedings
Asthma affects approximately 13% of Canadian children.1 Severe asthma, whose control requires high-dose inhaled corticosteroids (ICS) and a second controller medication or daily systemic corticoste...
- 10 June 2026
- Published by Taylor & Francis in Canadian Journal of Respiratory, Critical Care, and Sleep Medicine
- Vol. 10 (4) , 1-9
Open Access2025 Canadian Pediatric Severe Asthma Stakeholders’ Forum proceedings
Asthma affects approximately 13% of Canadian children.1 Severe asthma, whose control requires high-dose inhaled corticosteroids (ICS) and a second controller medication or daily systemic corticoste...
- 8 May 2026
- Published by Wiley in Paediatric and Perinatal Epidemiology
- Vol. 40 (4) , 497-499
RSV and Childhood Asthma: Cause, Consequence or a Question of Design?
- 8 May 2026
- Published by Wiley in Paediatric and Perinatal Epidemiology
- Vol. 40 (4) , 497-499
RSV and Childhood Asthma: Cause, Consequence or a Question of Design?
- Open Access
Causal Language Detection using Text-Document Features: Methodology and Insights from 10 Years of Gut Microbiome Research
Detecting causal language in scientific literature is critical for understanding how research fields frame evidence and inform interventions and policies, yet existing approaches commonly rely on manual annotation. The objective of this study was to evaluate four classifiers for detecting causal language and to apply the best-performing model to assess trends in microbiome research. Microbiome research, with its rapidly expanding observational literature, provides a relevant case study. We extracted Term Frequency–Inverse Document Frequency (TF-IDF) features from the last three sentences of available publication abstracts and trained four classifiers (L1- and L2-regularized logistic regression, Random Forest, and eXtreme Gradient Boosting) to detect causal language. A total of 475 sentences, as determined pragmatically based on annotation feasibility and observed stabilization of model performance, were manually labeled as causal or non-causal following established guidelines for systematic evaluation of causal language in observational health research. Of these, 75% of sentences were used for training and 25% for testing. L1-regularized logistic regression achieved the highest performance (accuracy 76%, F1 72%, prevalence detection accuracy 95%, sensitivity 72%, and specificity 80%) and was applied to 20,022 human gut microbiome abstracts published between 2015 and 2025 grouped into 20 thematic topics using structural topic modeling. Predicted causal language prevalence declined from 52% to 44% between 2015 and 2018, then rose to 51% by 2025, with notable variation across topics (range: 43.1–53.3%). Temporal trends differed across subfields, with increases in Metabolic disorders, Fecal microbiota transplantation, and decreases in Biomarkers and prediction, Antibiotic resistance, and In vitro fermentation . Analysis of influential words confirmed that causal meaning is primarily driven by verbs and modifiers lexically signaling change or intervention. The proposed approach for identifying causal claims in scientific abstracts enables systematic and automated, scalable assessment of how evidence is framed. Its application to the microbiome field highlighted heterogeneity in the reporting of causal relationships and informing the interpretation of microbiome findings for clinical and public health decision-making.
Open AccessCausal Language Detection using Text-Document Features: Methodology and Insights from 10 Years of Gut Microbiome Research
Detecting causal language in scientific literature is critical for understanding how research fields frame evidence and inform interventions and policies, yet existing approaches commonly rely on manual annotation. The objective of this study was to evaluate four classifiers for detecting causal language and to apply the best-performing model to assess trends in microbiome research. Microbiome research, with its rapidly expanding observational literature, provides a relevant case study. We extracted Term Frequency–Inverse Document Frequency (TF-IDF) features from the last three sentences of available publication abstracts and trained four classifiers (L1- and L2-regularized logistic regression, Random Forest, and eXtreme Gradient Boosting) to detect causal language. A total of 475 sentences, as determined pragmatically based on annotation feasibility and observed stabilization of model performance, were manually labeled as causal or non-causal following established guidelines for systematic evaluation of causal language in observational health research. Of these, 75% of sentences were used for training and 25% for testing. L1-regularized logistic regression achieved the highest performance (accuracy 76%, F1 72%, prevalence detection accuracy 95%, sensitivity 72%, and specificity 80%) and was applied to 20,022 human gut microbiome abstracts published between 2015 and 2025 grouped into 20 thematic topics using structural topic modeling. Predicted causal language prevalence declined from 52% to 44% between 2015 and 2018, then rose to 51% by 2025, with notable variation across topics (range: 43.1–53.3%). Temporal trends differed across subfields, with increases in Metabolic disorders, Fecal microbiota transplantation, and decreases in Biomarkers and prediction, Antibiotic resistance, and In vitro fermentation . Analysis of influential words confirmed that causal meaning is primarily driven by verbs and modifiers lexically signaling change or intervention. The proposed approach for identifying causal claims in scientific abstracts enables systematic and automated, scalable assessment of how evidence is framed. Its application to the microbiome field highlighted heterogeneity in the reporting of causal relationships and informing the interpretation of microbiome findings for clinical and public health decision-making.
- Open Access
- 11 September 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 14 (1) , e70517
Using mHealth to Predict Asthma Exacerbations in Children and Adolescents (Mobile Health for Kids With Asthma): Protocol for an Observational Study
Background: Asthma exacerbation is a major cause of emergency department visits in children and adolescents. Most of the existing asthma prediction scores and biomarkers are designed to predict severe exacerbations in the medium to long term. Mobile health (mHealth) is a promising approach for integrating real-time, multimodal data to improve the prediction of asthma exacerbation. Using mHealth can enable the identification of at-risk children and the implementation of timely interventions. Objective: The primary objective of the Mobile Health for Kids With Asthma (MoKA) study is to develop a validated predictive model for imminent asthma exacerbation in children using multimodal data, including participant-reported questionnaires through the RespiSentinel mobile app, augmented with publicly sourced environmental and epidemiological data. Furthermore, we will evaluate the association between the frequency of nocturnal cough measured in real time and asthma control and severe asthma exacerbation, and the acceptability of the RespiSentinel app in asthma self-management. Methods: This is a prospective cohort study with in-person and remote recruitment at 7 tertiary pediatric centers in Canada. Parents of children aged between 1 and 17 years, as well as children who have experienced at least one wheezing episode or asthma exacerbation during the 12 months before recruitment, will be eligible to participate (estimated number of children: n=2000). The planned duration of study participation is 6 months following the date of enrollment (cohort entry), regardless of the number of asthma exacerbations during the follow-up period. The primary outcome will be asthma exacerbation defined by asthma symptoms requiring systemic corticosteroid use and an urgent care or emergency department visit or hospitalization. The predictive model will be created using questionnaire data on asthma control via the RespiSentinel app as well as by integrating publicly available local daily data on air pollutant levels (National Air Pollution Surveillance Program) and weekly prevalence of respiratory viruses (National Canadian Respiratory Virus Detection Surveillance Program). Nocturnal cough frequency will be determined by using nighttime audio recordings, and their contribution to predict imminent asthma exacerbation will be evaluated. Acceptability of the RespiSentinel app will be assessed through an app-based questionnaire. Results: We will train and validate an asthma exacerbation prediction model using multimodal data sources. This approach may help patients, their families, and health professionals anticipate upcoming loss of asthma control and take the necessary steps to prevent a severe asthma exacerbation. Conclusions: The MoKA study will harness real-time mHealth data to identify children at imminent risk of asthma exacerbation with the ultimate goal of designing timely interventions to prevent morbidity in this group of patients.
- 11 September 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 14 (1) , e70517
Open AccessUsing mHealth to Predict Asthma Exacerbations in Children and Adolescents (Mobile Health for Kids With Asthma): Protocol for an Observational Study
Background: Asthma exacerbation is a major cause of emergency department visits in children and adolescents. Most of the existing asthma prediction scores and biomarkers are designed to predict severe exacerbations in the medium to long term. Mobile health (mHealth) is a promising approach for integrating real-time, multimodal data to improve the prediction of asthma exacerbation. Using mHealth can enable the identification of at-risk children and the implementation of timely interventions. Objective: The primary objective of the Mobile Health for Kids With Asthma (MoKA) study is to develop a validated predictive model for imminent asthma exacerbation in children using multimodal data, including participant-reported questionnaires through the RespiSentinel mobile app, augmented with publicly sourced environmental and epidemiological data. Furthermore, we will evaluate the association between the frequency of nocturnal cough measured in real time and asthma control and severe asthma exacerbation, and the acceptability of the RespiSentinel app in asthma self-management. Methods: This is a prospective cohort study with in-person and remote recruitment at 7 tertiary pediatric centers in Canada. Parents of children aged between 1 and 17 years, as well as children who have experienced at least one wheezing episode or asthma exacerbation during the 12 months before recruitment, will be eligible to participate (estimated number of children: n=2000). The planned duration of study participation is 6 months following the date of enrollment (cohort entry), regardless of the number of asthma exacerbations during the follow-up period. The primary outcome will be asthma exacerbation defined by asthma symptoms requiring systemic corticosteroid use and an urgent care or emergency department visit or hospitalization. The predictive model will be created using questionnaire data on asthma control via the RespiSentinel app as well as by integrating publicly available local daily data on air pollutant levels (National Air Pollution Surveillance Program) and weekly prevalence of respiratory viruses (National Canadian Respiratory Virus Detection Surveillance Program). Nocturnal cough frequency will be determined by using nighttime audio recordings, and their contribution to predict imminent asthma exacerbation will be evaluated. Acceptability of the RespiSentinel app will be assessed through an app-based questionnaire. Results: We will train and validate an asthma exacerbation prediction model using multimodal data sources. This approach may help patients, their families, and health professionals anticipate upcoming loss of asthma control and take the necessary steps to prevent a severe asthma exacerbation. Conclusions: The MoKA study will harness real-time mHealth data to identify children at imminent risk of asthma exacerbation with the ultimate goal of designing timely interventions to prevent morbidity in this group of patients.
- Open Access
- 24 May 2025
- Published by Elsevier in Pharmacological Research
- Vol. 217, 107792
Pediatric infections in the first year of life following maternal biologic exposure for autoimmune disorder treatment: A systematic review
- 24 May 2025
- Published by Elsevier in Pharmacological Research
- Vol. 217, 107792
Open AccessPediatric infections in the first year of life following maternal biologic exposure for autoimmune disorder treatment: A systematic review
- Open Access
- 23 December 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Using mHealth to Predict Asthma Exacerbations in Children and Adolescents (Mobile Health for Kids With Asthma): Protocol for an Observational Study (Preprint)
BACKGROUND Asthma exacerbation is a major cause of emergency department visits in children and adolescents. Most of the existing asthma prediction scores and biomarkers are designed to predict severe exacerbations in the medium to long term. Mobile health (mHealth) is a promising approach for integrating real-time, multimodal data to improve the prediction of asthma exacerbation. Using mHealth can enable the identification of at-risk children and the implementation of timely interventions. OBJECTIVE The primary objective of the Mobile Health for Kids With Asthma (MoKA) study is to develop a validated predictive model for imminent asthma exacerbation in children using multimodal data, including participant-reported questionnaires through the RespiSentinel mobile app, augmented with publicly sourced environmental and epidemiological data. Furthermore, we will evaluate the association between the frequency of nocturnal cough measured in real time and asthma control and severe asthma exacerbation, and the acceptability of the RespiSentinel app in asthma self-management. METHODS This is a prospective cohort study with in-person and remote recruitment at 7 tertiary pediatric centers in Canada. Parents of children aged between 1 and 17 years, as well as children who have experienced at least one wheezing episode or asthma exacerbation during the 12 months before recruitment, will be eligible to participate (estimated number of children: n=2000). The planned duration of study participation is 6 months following the date of enrollment (cohort entry), regardless of the number of asthma exacerbations during the follow-up period. The primary outcome will be asthma exacerbation defined by asthma symptoms requiring systemic corticosteroid use and an urgent care or emergency department visit or hospitalization. The predictive model will be created using questionnaire data on asthma control via the RespiSentinel app as well as by integrating publicly available local daily data on air pollutant levels (National Air Pollution Surveillance Program) and weekly prevalence of respiratory viruses (National Canadian Respiratory Virus Detection Surveillance Program). Nocturnal cough frequency will be determined by using nighttime audio recordings, and their contribution to predict imminent asthma exacerbation will be evaluated. Acceptability of the RespiSentinel app will be assessed through an app-based questionnaire. RESULTS We will train and validate an asthma exacerbation prediction model using multimodal data sources. This approach may help patients, their families, and health professionals anticipate upcoming loss of asthma control and take the necessary steps to prevent a severe asthma exacerbation. CONCLUSIONS The MoKA study will harness real-time mHealth data to identify children at imminent risk of asthma exacerbation with the ultimate goal of designing timely interventions to prevent morbidity in this group of patients.
- 23 December 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessUsing mHealth to Predict Asthma Exacerbations in Children and Adolescents (Mobile Health for Kids With Asthma): Protocol for an Observational Study (Preprint)
BACKGROUND Asthma exacerbation is a major cause of emergency department visits in children and adolescents. Most of the existing asthma prediction scores and biomarkers are designed to predict severe exacerbations in the medium to long term. Mobile health (mHealth) is a promising approach for integrating real-time, multimodal data to improve the prediction of asthma exacerbation. Using mHealth can enable the identification of at-risk children and the implementation of timely interventions. OBJECTIVE The primary objective of the Mobile Health for Kids With Asthma (MoKA) study is to develop a validated predictive model for imminent asthma exacerbation in children using multimodal data, including participant-reported questionnaires through the RespiSentinel mobile app, augmented with publicly sourced environmental and epidemiological data. Furthermore, we will evaluate the association between the frequency of nocturnal cough measured in real time and asthma control and severe asthma exacerbation, and the acceptability of the RespiSentinel app in asthma self-management. METHODS This is a prospective cohort study with in-person and remote recruitment at 7 tertiary pediatric centers in Canada. Parents of children aged between 1 and 17 years, as well as children who have experienced at least one wheezing episode or asthma exacerbation during the 12 months before recruitment, will be eligible to participate (estimated number of children: n=2000). The planned duration of study participation is 6 months following the date of enrollment (cohort entry), regardless of the number of asthma exacerbations during the follow-up period. The primary outcome will be asthma exacerbation defined by asthma symptoms requiring systemic corticosteroid use and an urgent care or emergency department visit or hospitalization. The predictive model will be created using questionnaire data on asthma control via the RespiSentinel app as well as by integrating publicly available local daily data on air pollutant levels (National Air Pollution Surveillance Program) and weekly prevalence of respiratory viruses (National Canadian Respiratory Virus Detection Surveillance Program). Nocturnal cough frequency will be determined by using nighttime audio recordings, and their contribution to predict imminent asthma exacerbation will be evaluated. Acceptability of the RespiSentinel app will be assessed through an app-based questionnaire. RESULTS We will train and validate an asthma exacerbation prediction model using multimodal data sources. This approach may help patients, their families, and health professionals anticipate upcoming loss of asthma control and take the necessary steps to prevent a severe asthma exacerbation. CONCLUSIONS The MoKA study will harness real-time mHealth data to identify children at imminent risk of asthma exacerbation with the ultimate goal of designing timely interventions to prevent morbidity in this group of patients.
- Open Access
- 13 November 2024
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 35 (11) , e14279
Are single‐nucleotide polymorphisms previously linked to inhaled corticosteroid response associated with obese‐asthma in children?
- 13 November 2024
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 35 (11) , e14279
Open AccessAre single‐nucleotide polymorphisms previously linked to inhaled corticosteroid response associated with obese‐asthma in children?